ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2044

Secondary Prevention of Cardiovascular Disease Is Incomplete in a Systemic Lupus Erythematosus Population-Based Cohort

Suzana John1, Cristina Drenkard2, Gaobin Bao2 and S. Sam Lim2, 1Rheumatology, Emory University, Atlanta, GA, 2Division of Rheumatology, Emory University School of Medicine, Atlanta, GA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: SLE and cardiovascular disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Measures and Measurement of Healthcare Quality Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Cardiovascular disease (CVD) is a common cause of morbidity and mortality in systemic lupus erythematosus (SLE).  We know that a combination of traditional cardiovascular disease (CVD) risk factors and dysregulation of the immune system play a role in the pathogenesis. Strict adherence to  established preventive measures in these patients is important. This study evaluated secondary prevention of CVD in a large population-based SLE cohort.

Methods:

Georgians Organized Against Lupus (GOAL) is a population-based cohort of patients with validated SLE surveyed annually and matched to the Georgia Hospital Discharge Database to capture all hospitalizations throughout the state. Those with CVD were identified from responses to the validated Self-Administered Brief Index of Lupus Damage. CVD related hospitalizations were identified based on the first 3 admission codes.

Results:

164 out of 685 respondents had CVD. Patients with CVD were more often older, black, poor, unemployed and on Medicare/Medicaid. Blood pressure was monitored very well. Most but not all received an annual check-up and cholesterol monitoring. Measures that were met the least included not smoking, adequate physical activity and aspirin adherence. Smokers were more often on Medicare/Medicaid than non-smokers (p=0.015).

Conclusion:

SLE patients with known CVD are at high risk for recurrent cardiovascular events  and mortality, making prevention a crucial and cost effective priority. There continues to be significant room for improvement in many preventive measures. Further study may direct education and resources to improve performance in these areas.

           

Table 1: Socio-demographic description of the GOAL Cohort

Descriptors

GOAL Cohort

(N=685)

CVD status

Non-CVD

(n=519)

CVD

(N=164)

P Value

Age  ( mean ± SD)

48.1 ± 13.2

46.5 ± 12.7

53.1 ± 13.3

<0.0001

Gender

     Male

40 (5.8)

26 (5.0)

14 (8.5)

0.094

     Female

645 (94.2)

493 (95.0)

150 (91.5)

Race

     Black

529 (77.2)

392 (75.5)

135 (82.3)

0.17

     White

144 (21.0)

118 (22.7)

26 (15.9)

Living below poverty level

256 (37.3)

183 (35.2)

72 (44.0)

0.019

Unemployed or disabled

356 (52.0)

231 (44.5)

124 (75.6)

<0.0001

Insurance

     Private

291 (42.5)

239 (46.1)

52 (31.7)

0.0012

     Medicaid

182 (26.6)

116 (22.4)

66 (40.2)

<0.0001

     Medicare

245 (35.8)

150 (28.9)

95 (57.9)

<0.0001

     Underinsured/uninsured

125(18.2)

99 (19.1)

25 (15.2)

0.27

Table 2: Meeting secondary and other preventive measures in the GOAL Cohort with known CVD within the past year

GOAL Cohort with CVD(N=164)

Met

N (%)

Did Not Meet

N (%)

Blood pressure monitoring

157 (96.9)

5 (3.1)

Annual check up

132 (84.6)

24 (15.4)

Cholesterol monitoring

130 (80.2)

32 (19.7)

Not smoking

107 (69.0)

48 (31.0)

Flu vaccination

103 (63.6)

59 (36.4)

Aspirin adherence

96 (60.4)

63 (39.6)

Cardiology visit

84 (58.3)

60 (41.7)

Adequate physical activity

90 (56.3)

70 (43.7)

·         Physical activity : any exercise within the past month other than regular job


Disclosure: S. John, None; C. Drenkard, None; G. Bao, None; S. S. Lim, None.

To cite this abstract in AMA style:

John S, Drenkard C, Bao G, Lim SS. Secondary Prevention of Cardiovascular Disease Is Incomplete in a Systemic Lupus Erythematosus Population-Based Cohort [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/secondary-prevention-of-cardiovascular-disease-is-incomplete-in-a-systemic-lupus-erythematosus-population-based-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/secondary-prevention-of-cardiovascular-disease-is-incomplete-in-a-systemic-lupus-erythematosus-population-based-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology